secwatch.observer — SEC 8-K summary
======================================

Issuer:     NANOVIRICIDES, INC. (NNVC)
CIK:        0001379006
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001104659-24-005254
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NanoViricides shareholders re-elect Anil Diwan as director, approve executive compensation and preferred stock grant
--------------------------------------------------------------------------------

- At the January 13, 2024 annual meeting, shareholders re-elected Anil Diwan as Class I director with 5,590,467 votes for, 308,092 against, 488,175 abstentions, and 3,056,966 broker non-votes.
- An advisory vote on named executive officer compensation passed with 5,572,378 votes for and 788,423 against, plus 3,056,966 broker non-votes.
- Approval of a grant of 10,204 Series A Convertible Preferred Shares to Anil Diwan in connection with his employment extension passed with 5,508,079 votes for, 844,079 against.
- Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending June 30, 2024 passed with 9,165,259 votes for, 152,847 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/tm243719d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-005254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer